M 108101Alternative Names: M-108101
Latest Information Update: 03 Jun 2016
At a glance
- Originator Maruho
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Acne
Most Recent Events
- 03 Jun 2016 Discontinued - Phase-II for Acne in Japan (Topical)